T. Rabe
About
In The Last Decade
T. Rabe
122 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 117
- Reproductive Medicine 642
- Public Health, Environmental and Occupational Health 592
- Endocrinology, Diabetes and Metabolism 440
- Genetics 351
- Molecular Biology 299
Countries citing papers authored by T. Rabe
This map shows the geographic impact of T. Rabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Rabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Rabe more than expected).
Fields of papers citing papers by T. Rabe
This network shows the impact of papers produced by T. Rabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Rabe. The network helps show where T. Rabe may publish in the future.
Co-authorship network of co-authors of T. Rabe
This figure shows the co-authorship network connecting the top 25 collaborators of T. Rabe. A scholar is included among the top collaborators of T. Rabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Rabe. T. Rabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 39 | |
| 3 | Dehydroepiandrosterone and its Sulfate Joint Statement by the German Society for Gynecological Endocrinology and Reproductive Medicine [DGGEF] and the German Professional Association of Gynecologists [BVF]) | 2 |
| 4 | Intermittierende Gabe von Ulipristalacetat zur konservativen Myomtherapie und Blutungskontrolle bei Hypermenorrhoe durch Uterus myomatosus Gemeinsame Stellungnahme der DGGGEF e.V. und des BVF e.V. | 0 |
| 5 | Hirsutismus – Medikamentöse Therapie Gemeinsame Stellungnahme der Deutschen Gesellschaft für Gynäkologische Endokrinologie und Fortpflanzungsmedizin e.V. und des Berufsverbands der Frauenärzte e.V. | 1 |
| 6 | Bewertung von ovarieller Reserve und Fertilität mit steigendem Lebensalter | 0 |
| 7 | Diagnostische und therapeutische Optionen bei Patientinnen mit Myomen: Myomembolisation | 0 |
| 8 | Hormonimplantate zur Kontrazeption bei der Frau | 2 |
| 9 | Neue diagnostische und therapeutische Optionen bei Patientinnen mit Myomen - Hochintensiver fokussierter Ultraschall | 2 |
| 10 | Ulipristal Acetate for Symptomatic Uterine Fibroids and Myoma-Related Hypermenorrhea Joint Statement by the German Society for Gynecological Endocrinology and Reproductive Medicine (DGGEF) and the German Professional Association of Gynecologists (BVF) | 0 |
| 11 | Depotgestagene zur Kontrazeption bei der FrauGemeinsame Stellungnahme der Deutschen Gesellschaft für Gynäkologische Endokrinologie und Fortpflanzungsmedizin (DGGEF) e.V. und des Berufsverbands der Frauenärzte (BVF) e. V. | 0 |
| 12 | Contraception and Thrombophilia - A statement from the German Society for Gynecological Endo- crinology and Reproductive Medicine (DGGEF e.V.) and the Professional Association of German Gynaecologists (BVF e.V.) | 12 |
| 13 | Oral Contraceptive Pills: Combinations, Dosages and the Rationale behind 50 Years or Oral Hormonal Contraceptive Development | 0 |
| 14 | Einfluss von hormonellen Kontrazeptiva auf das Größenwachstum und den Knochenbau von 12-14-jährigen Mädchen: Stellungnahme der DGGEF | 1 |
| 15 | Kontrazeption und Schwangerschaft bei Frauen mit Epilepsie - Eine Stellungnahme der DGGEF | 1 |
| 16 | Hormone Replacement Therapy After Breast Cancer | 0 |
| 17 | Schwangerschaften unter verschiedenen kontrazeptiven Methoden | 1 |
| 18 | Contraception - Update and Trends | 5 |
| 19 | Gemeinsame Stellungnahme der Deutschen Gesellschaft für Gynäkologische Endokrinologie und Fortpflanzungsmedizin e.V. (DGGEF e.V.) in Zusammenarbeit mit dem Berufsverband der Frauenärzte e.V.: Empfängnisverhütung - Familienplanung in Deutschland | 3 |
| 20 | Female contraception : update and trends | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.